Veterinary Medicine Information website

Nobivac Parvo-C

Not authorised
  • Canine parvovirus, strain 154, Live
  • Water for injection
Download as PDF

Product identification

Medicine name:
Nobivac Parvo-C
Active substance:
  • Canine parvovirus, strain 154, Live
  • Water for injection
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parvovirus, strain 154, Live
    10000000.00
    50% tissue culture infectious dose
    /
    1.00
    millilitre(s)
  • Water for injection
    1.00
    other
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Norway
Package description:
  • Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Cardboard containing 50 single dose vials of the diluent
  • Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Cardboard containing 10 single dose vials of the diluent
  • Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Cardboard containing 50 single dose vials of the vaccine
  • Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Cardboard containing 10 single dose vials of the vaccine
  • Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Cardboard containing 50 single dose vials. The diluent is packed together with the vaccine
  • Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Cardboard containing 10 single dose vials. The diluent is packed together with the vaccine
  • Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Plastic box containing 50 single dose vials of the diluent
  • Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Plastic box containing 10 single dose vials of the diluent
  • Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Plastic box containing 50 single dose vials of the vaccine
  • Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Plastic Box containing 10 single dose vials of the vaccine
  • Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Plastic box containing 10 single dose vials. The diluent is packed together with the vaccine
  • Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Plastic box containing 50 single dose vials. The diluent is packed together with the vaccine

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 05-3331
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0160/001

Documents

Summary of Product Characteristics

English (PDF)
Published on: 8/03/2026
Download
Norwegian (PDF)
Published on: 19/04/2022
Download

Combined File of all Documents

English (PDF)
Published on: 8/03/2026
Download